Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Wattana Karnpaet PCL's Revenue for the
three
months ended in Mar. 2026 was ฿109.7 Mil. Wattana Karnpaet PCL's average Accounts Receivable for the
three
months ended in Mar. 2026 was ฿24.6 Mil.
Hence, Wattana Karnpaet PCL's Receivables Turnover for the
three
months ended in Mar. 2026 was 4.46.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Wattana Karnpaet PCL Receivables Turnover Related Terms
Wattana Karnpaet PCL Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Wattana Karnpaet PCL's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BKK:NEW vs HCA, THC, DVA: Receivables Turnover Comparison
For the Medical Care Facilities subindustry, Wattana Karnpaet PCL's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Wattana Karnpaet PCL Receivables Turnover vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Wattana Karnpaet PCL's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Wattana Karnpaet PCL's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Wattana Karnpaet PCL (BKK:NEW) has a Receivables Turnover of 4.46 as of Mar. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Wattana Karnpaet PCL and its competitors. According to the industry distribution chart, Wattana Karnpaet PCL ranks #144 out of 657 companies in the Healthcare Providers & Services industry, placing it in the top 21.9%.
Is Wattana Karnpaet PCL's Receivables Turnover too high?
Wattana Karnpaet PCL's current Receivables Turnover is 4.46. The Healthcare Providers & Services industry median Receivables Turnover is 7.74. Wattana Karnpaet PCL's value of 4.46 is 42.4% below this industry median. Based on the distribution chart, Wattana Karnpaet PCL ranks #144 out of 657 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Wattana Karnpaet PCL has a GF Score™ of 76/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Wattana Karnpaet PCL's Receivables Turnover compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Wattana Karnpaet PCL ranks #144 out of 657 companies for Receivables Turnover. This places Wattana Karnpaet PCL in the top 22% of its industry — outperforming the majority of peers. The industry median Receivables Turnover is 7.74. Wattana Karnpaet PCL's value of 4.46 is 42.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Healthcare Providers & Services company?
The median Receivables Turnover among Healthcare Providers & Services companies is 7.74, based on 657 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Wattana Karnpaet PCL's current Receivables Turnover of 4.46 is 42.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Wattana Karnpaet PCL and its competitors. For the Healthcare Providers & Services industry, the median Receivables Turnover is 7.74 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Wattana Karnpaet PCL's current Receivables Turnover is 4.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Wattana Karnpaet PCL stock overvalued right now?
Based on GuruFocus' analysis, Wattana Karnpaet PCL (BKK:NEW) is currently considered Fairly Valued. The stock's GF Value™ is ฿96.87, compared to a current price of ฿95.00 — trading 1.9% below its estimated fair value. The current Receivables Turnover is 4.46 and 42.4% below the Healthcare Providers & Services industry median of 7.74. Wattana Karnpaet PCL's overall GF Score™ is 76/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Wattana Karnpaet PCL (BKK:NEW), the current Receivables Turnover is 4.46 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Wattana Karnpaet PCL (BKK:NEW) Overvalued in 2026?
Based on GuruFocus' analysis, Wattana Karnpaet PCL stock appears to be undervalued.
The current stock price of ฿95.00 is trading 1.9% below its estimated GF Value™ of ฿96.87.
GuruFocus considers Wattana Karnpaet PCL to be Fairly Valued.
Key valuation signals for BKK:NEW:
Receivables Turnover: 4.46
GF Value™: ฿96.87 vs. price of ฿95.00 (1.9% below fair value)
Industry Position: 42.4% below the Healthcare Providers & Services median (#144 of 657)
No single metric tells the full story. See the BKK:NEW stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Wattana Karnpaet PCL is engaged in the operation of a hospital under the name North Eastern Wattana Hospital. It has a single segment of operation, namely the hospital and medical trading business. The company earns revenue from hospital, revenue from sales of medicines, and revenue from hospital rooms, which are derived from the provision of services to various types and a large number of customers. Geographically, the company's operations are carried out in Thailand.
76GF Score
Get the complete analysis for BKK:NEW
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:NEW has been successfully added to your 
